Study on approaches to expedite and simplify forced degradation of eplerenone

Journal of Liquid Chromatography and Related Technologies

Volumn 36, Issue 15, 2013, Pages 2156-2165

  Sonawane, Sandeep ^a   Gide, Paraag ^a  

^a MET College of Engineering   (India)

Author keywords

eplerenone; experimental design; microwave assisted forced degradation; molecular ion peak; surface response curve; transformation

Indexed keywords

EPLERENONE; FORCED DEGRADATION; MOLECULAR ION PEAKS; SURFACE RESPONSE; TRANSFORMATION;

DEGRADATION; DESIGN OF EXPERIMENTS;

ION SOURCES;

ACID; ALKALI; EPLERENONE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEGRADATION; FACTORIAL DESIGN; HEAT; IRRADIATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROWAVE OVEN; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 84879296623     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2012.717054     Document Type: Article

References (11)

1. Klick, S.; Muijselaar, P.; Eichinger, T.; Korn, C.; Gerding, T.;Debert, A.; Griend, C.; Beld, C.; Somsen, G.; Jong, G. Towards Generic Approach for Stress Testing of Drug Substances and Drug Products. Pharm Tech. 2005, 48-66.
2. ICH. Stability Testing of New Drug Substances and Products, Q1A (R2), International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. IFPMA, Geneva. http://www.ich.org (Accessed January 2012), 2003.
3. Singh, S.; Bakshi, M. Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs. Pharm. Tech. 2000, 1-14.
4. Canddick, S. Microwave Assisted Organic Reactions. Tetrahedron 1995, 51, 10430-10432. doi::10.1016=0040-4020(95)00662-R
5. Wathey, B.; Tierney, J.; Lidstrom, P.; Westman, J. The Impact of Microwave-Assisted Organic Chemistry on Drug Discovery. Drug Disc. Today 2002, 7, 373-380. doi: 10.1016=S1359-6446(02)02178-5
6. Spertus, J.; Tooley, J.; Jones, P.; Poston, C.; Mahoney, E.; Deedwania, P.; Hurley, S.; Pitt, B.; Weintraub, W. Expanding the Outcomes in Clinical Trials of Heart Failure: The Quality of Life and Economic Components of EPHESUS (Eplerenonés neuroHormonal Efficacy and Survival Study). Am. Heart J. 2002, 143, 636-642. doi: 0.1067=mhj.2002.120775.
7. Elyani, J.; Rocha, R.; Cook, C.; Tolbert, D.; Levin, S.; Roniker, B.; Workman, L.; Sing, Y.; Whelihan, B. Plerenone. A Selective Aldosterone Receptor Antagonist (SARA). Cadriovasc. Drug Rev. 2001, 19, 185-200. doi: 0.1111=j.1527-3466.2001.tb00064.x
8. Zhang, J.; Fast, D.; Breau, A. A Validated SPE - LC - MS=MS Assay for Eplerenone and Its Hydrolyzed Metabolite in Human Urine. J. Pharm. Biomed. Anal. 2003, 31, 103-115. doi: 10.1016= S0731-7085(02)00595-2.
9. Zhang, J.; Fast, D.; Breau, A. Development and Validation of Liquid Chromatography- Tandem Mass Spectrometric Assay for Eplerenone and Its Hydrolyzed Metabolite in Human Plasma. J. Chrom. B. 2003, 787, 333-344. doi: 10.1016=S1570-0232(02)00964
10. Rane, V.; Patil, K.; Sangshetti, J.; Yeole, R.; Shinde, D. Stability-Indicating RP-HPLC Method for Analysis of Eplerenone in the Bulk Drug and in Pharmaceutical Dosage Form. Acta Chromatogr. 2009, 4, 619-629. doi: 10.1556=AChrom.21.2009.4.8.
11. Sonawane, S.; Gide, P. An Experimental Design Approach for the Forced Degradation Studies and Development of a Stability-Indicating Method for Eplerenone in Tablets. J. Liq. Chromatogr. Rel. Technol. 2011, 34, 2020-2031. doi: 10.1080=10826076.2011.582913